Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene

Hum Gene Ther. 1996 Mar 1;7(4):551-63. doi: 10.1089/hum.1996.7.4-551.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I

MeSH terms

  • Clinical Protocols
  • Gene Transfer Techniques
  • Genetic Therapy*
  • Humans
  • Immunotherapy*
  • Interleukin-2 / genetics*
  • Melanoma / genetics
  • Melanoma / secondary
  • Melanoma / therapy*
  • Transfection
  • Vaccines / genetics*

Substances

  • Interleukin-2
  • Vaccines